Phase I Study of Pharmacokinetics and Safety of Ravidasvir in Combination With Ritonavir-boosted Danoprevir in Single and Multiple Doses in Healthy Participants
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Danoprevir/ritonavir (Primary) ; Ravidasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Ascletis
- 01 Jul 2018 Status changed from active, no longer recruiting to completed.
- 15 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jan 2018.
- 15 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Feb 2018.